Aster DM Quality Care terminated its O&M and Medical Services agreements with DM Education and Research Foundation, ceasing related hospital operations. The Aster Wayanad hospital contributed 1.20% of turnover; no consideration was received.
Aster DM approved converting a Rs 102.46 Crore subsidiary loan into equity shares. It also approved terminating DMERF operations and medical services agreements.
Aster DM Quality Care released a press release on its Q2 FY27 unaudited results, reporting revenue up 19% to Rs 2,829 crore. Normalised PAT rose 34% to Rs 281 crore.
Aster DM Quality Care Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026. This is a routine regulatory compliance disclosure.
Aster DM Quality Care Limited filed the transcript of its 18th Annual General Meeting held on September 28, 2026, which covered the company's annual strategic and performance updates.
Aster DM Quality Care announced the retirement of Independent Director Purana Housdurgam Vijayadeepti and appointed Neela Bhattacherjee as an Additional Independent Director.
Aster DM Quality Care Limited held its 18th Annual General Meeting on September 28, 2026. Shareholders deliberated on five resolutions, including the adoption of financial statements and increasing borrowing limits.
Aster DM Quality Care issued an addendum to its 18th AGM notice, providing additional information regarding the proposed capital allocation framework for shareholders.
ICRA upgraded KIMS Healthcare Management's long-term rating to AA (Stable) from AA-, removing it from Rating Watch. The upgrade reflects stronger parent support post-Aster-QCIL merger.
Catalyst Trusteeship released a pledge and created a new hold on Aster DM Quality Care shares. The encumbrance secures term loan facilities from Barclays and JPMorgan.
UMHL released a pledge and created a non-disposal undertaking over 2.49 Cr shares securing USD 210 million. The encumbrance backs UIPL's Barclays-JPMorgan loan facilities.
Aster DM announced KIMSHEALTH New Block adding ~184 beds by May 2028 at a cost of ₹134.4 Crore. The expansion addresses space constraints in Trivandrum.
Aster DM Quality Care has submitted its Integrated Annual Report for FY 2025-26 and the notice for its 18th Annual General Meeting scheduled for September 28, 2026.
Aster DM Quality Care Ltd announced its 18th Annual General Meeting scheduled for September 28, 2026, and submitted the Integrated Annual Report for FY 2025-26.
The promoter Moopen family acquired a 0.57% additional stake in Aster DM Quality Care for Rs.350.34 Crore. This increases their total shareholding to approximately 24.58%.
Aster DM Quality Care Ltd announced a capacity expansion of 184 beds at its material subsidiary, KIMS Health Care Management Limited, involving an investment of ₹134.4 Crore.
Aster DM Quality Care Limited announced the internal amalgamation of its step-down subsidiaries, Spiceretreat Hospitality and KIMSHEALTH Executive Leisure, to simplify the corporate group structure.
Aster DM Quality Care approved the amalgamation of its step-down subsidiaries, KIMSHEALTH Executive Leisure and Spiceretreat Hospitality Services. No cash consideration is involved in the scheme.
Aster DM Quality Care's subsidiary acquired a 14.21% stake in STS Holdings Limited for USD 44.11 million (approx. ₹419.09 Crore) as part of a strategic investment.
Aster DM Quality Care Limited issued a Postal Ballot notice seeking shareholder approval for director appointments, remuneration revisions, and a new 2026 ESOP scheme.
Union (Mauritius) Holdings disclosed the pledge of its shares to secure loan facilities totaling USD 210 Million (₹1,995 Crore) for existing indebtedness.
Catalyst Trusteeship Limited reported an additional pledge of 79,773,555 shares in Aster DM Quality Care Ltd. The total encumbered stake now reaches 9.7% following a merger.
Aster DM Quality Care received trading approval for 35,35,51,410 equity shares allotted under its Scheme of Amalgamation. These shares will be tradable from 17 August 2026.